NHIA News
Call for NHIA Board Member Candidates
NHIA is accepting applications for members of the association’s Board of Directors. Board members serve 3-year terms as representatives for their NHIA member organization. Seats are only open to provider members and are assigned at the organization level. Seats are currently available for: 1 national provider, 1 hospital provider, and 2 at-large providers (see below for definitions).
- National provider, defined as a multi-site organization with 20 or more locations.
- Hospital provider, defined as a provider that is wholly owned and operated as part of an acute care system.
- At-large members may include any type of provider.
Companies interested in serving on the NHIA Board of Directors must submit a letter of interest to Connie.Sullivan@NHIA.org no later than Friday, January 24. The letter should describe the company, history of involvement with NHIA, why the company would like to be considered for a board seat, and the name of the individual that would serve as its representative. Applicants are evaluated based on the following categories of participation in NHIA/NHIF:
- NHIA Committee Participation
- Fellow Participation
- Magazine Contribution
- Journal Contribution
- Research/Data Initiative Contribution
- Resident Program
- Advocacy (NHIA Hill Day Participation)
- Conference Participation
- NHIF Board Member/ Donation
###
NHIA is a trade association that represents companies accredited to provide medically necessary infusion therapies to patients with acute and chronic health conditions, as well as companies that manufacture and supply infusion related products and services. Infusion therapy involves patient-specific compounded medications, supplies, and a range of pharmacy, nursing, and other clinical services for delivering care to patients in the home or suite setting.
Related Posts
Congressional Spending Bill Falls Short on Home Infusion
December 18, 2024
The National Home Infusion Association (NHIA) expressed deep concern today regarding the recently proposed government funding bill, which includes major changes to the qualifying criteria for drugs under Medicare’s home infusion benefit but fails to address the underlying flaws that have plagued the program. Without fixing the structure of the benefit, Medicare beneficiaries in need of home infusions for treatment of a variety of medical conditions, including rare diseases, are unlikely to gain access to home-based care.
Melinta Joins NHIA Future of Infusion Advisory Council
December 1, 2024
The National Home Infusion Association (NHIA) and Melinta Therapeutics, LLC (Melinta), a commercial-stage company providing innovative therapies for acute and life-threatening illnesses, are pleased to announce the addition of Melinta to NHIA’s Future of Infusion Advisory Council (FIAC).
Patient, Stakeholder Groups Urge Congress to Address Medicare’s Failed Home Infusion Benefit
November 12, 2024
A diverse group of more than 35 patient and stakeholder groups are calling on Congress to address Medicare beneficiary access to home infusion services. In a letter to lawmakers, which brings together stakeholders from across the care continuum, the groups urge congressional leaders to advance the Preserving Patient Access to Home Infusion Act (S. 1976/H.R. 4104) and increase access to home infusion therapy for Medicare beneficiaries.
The post Call for NHIA Board Member Candidates appeared first on National Home Infusion Association.